NDC 25208-200
ZYPITAMAG
Pitavastatin Magnesium
ZYPITAMAG is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Medicure International Inc. The primary component is Pitavastatin.
| Product ID | 25208-200_07378b11-02d3-40f6-bea5-90ac775b04ed |
| NDC | 25208-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZYPITAMAG |
| Generic Name | Pitavastatin Magnesium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2021-05-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208379 |
| Labeler Name | Medicure International Inc |
| Substance Name | PITAVASTATIN |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA],HMG-CoA Reductase Inhibitor [EPC] |
| NDC Exclude Flag | N |
Packaging
NDC 25208-200-12
10 BLISTER PACK in 1 CARTON (25208-200-12) > 10 TABLET, FILM COATED in 1 BLISTER PACK
| Marketing Start Date | 2018-03-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 25208-200-13 [25208020013]
ZYPITAMAG TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA208379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2019-10-01 |
NDC 25208-200-12 [25208020012]
ZYPITAMAG TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA208379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2019-10-01 |
NDC 25208-200-14 [25208020014]
ZYPITAMAG TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA208379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2019-10-01 |
NDC 25208-200-09 [25208020009]
ZYPITAMAG TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA208379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2021-05-31 |
NDC 25208-200-15 [25208020015]
ZYPITAMAG TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA208379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2019-10-01 |
NDC 25208-200-10 [25208020010]
ZYPITAMAG TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA208379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2020-07-31 |
NDC 25208-200-11 [25208020011]
ZYPITAMAG TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA208379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-03-09 |
| Marketing End Date | 2019-10-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| PITAVASTATIN | 1 mg/1 |
OpenFDA Data
| SPL SET ID: | c8c50e03-5cb8-43f4-bdef-8edd12f1945f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- HMG-CoA Reductase Inhibitor [EPC]
NDC Crossover Matching brand name "ZYPITAMAG" or generic name "Pitavastatin Magnesium"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 25208-200 | ZYPITAMAG | Pitavastatin Magnesium |
| 25208-201 | ZYPITAMAG | Pitavastatin Magnesium |
| 25208-202 | ZYPITAMAG | Pitavastatin Magnesium |
| 70771-1116 | ZYPITAMAG | Pitavastatin Magnesium |
| 70771-1117 | ZYPITAMAG | Pitavastatin Magnesium |
| 70771-1118 | ZYPITAMAG | Pitavastatin Magnesium |
Trademark Results [ZYPITAMAG]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ZYPITAMAG 87730057 not registered Live/Pending |
Cadila Healthcare Limited 2017-12-21 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.